Keisuke Kataoka

Title: Keisuke Kataoka: Innovator in Cancer Treatment Prediction

Introduction

Keisuke Kataoka is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on predicting the effectiveness of PD-1/PD-L1 blockade therapy for patients suffering from malignant tumors.

Latest Patents

Kataoka holds a patent titled "Method of predicting effect of treatment by PD-1/PD-L1 blockade using abnormality of PD-L1 (CD274) as index." This invention aims to provide an effective method for predicting whether PD-1/PD-L1 blockade is beneficial for treating a subject with a malignant tumor. The method involves detecting abnormalities in the genome related to the effectiveness of the PD-1/PD-L1 blockade in tumor cells taken from the subject. When such abnormalities are present, the PD-1/PD-L1 blockade is evaluated as a useful treatment option.

Career Highlights

Throughout his career, Keisuke Kataoka has worked with esteemed institutions such as Kyoto University and the Japanese Foundation for Cancer Research. His research has been instrumental in advancing the understanding of cancer treatment and improving patient outcomes.

Collaborations

Kataoka has collaborated with notable colleagues, including Seishi Ogawa and Kengo Takeuchi. These partnerships have further enriched his research and contributed to the development of innovative treatment methods.

Conclusion

Keisuke Kataoka's work in predicting the effectiveness of cancer treatments showcases his dedication to improving patient care. His innovative patent and collaborations highlight the importance of research in the fight against cancer.